Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Naykhin AN"'
Autor:
Isakova-Sivak, Irina, Korenkov, Daniil, Smolonogina, Tatiana, Tretiak, Tatiana, Donina, Svetlana, Rekstin, Andrey, Naykhin, Anatoly, Shcherbik, Svetlana, Pearce, Nicholas, Chen, Li-Mei, Bousse, Tatiana, Rudenko, Larisa
Publikováno v:
In Virology January 2017 500:209-217
Autor:
I. V. Losev, S. A. Donina, G. D. Petukhova, D. A. Korenkov, M. K. Erofeeva, M. A. Stukova, L. G. Rudenko, A. N. Naykhin
Publikováno v:
Медицинская иммунология, Vol 19, Iss 4, Pp 375-386 (2017)
Over last years, a novel strategy for vaccination of people against potentially pandemic influenza A viruses is actively developed worldwide, i.e., a combined (prime-boost) vaccination. It provides amplification (boosting) of immune response for a va
Externí odkaz:
https://doaj.org/article/46686d32f94d403882ae8151ee8a087f
Autor:
Rudenko, Larisa, Isakova-Sivak, Irina, Naykhin, Anatoly, Kiseleva, Irina, Stukova, Marina, Erofeeva, Mariana, Korenkov, Daniil, Matyushenko, Victoria, Sparrow, Erin, Kieny, Marie-Paule
Publikováno v:
In The Lancet Infectious Diseases March 2016 16(3):303-310
Autor:
Rudenko, Larisa, Kiseleva, Irina, Stukova, Marina, Erofeeva, Marianna, Naykhin, Anatoly, Donina, Svetlana, Larionova, Natalie, Pisareva, Maria, Krivitskaya, Vera, Flores, Jorge
Publikováno v:
In Vaccine 22 September 2015 33(39):5110-5117
Publikováno v:
Медицинская иммунология, Vol 18, Iss 2, Pp 129-138 (2016)
There are many data worldwide which suggest that the methods for evaluation of influenza vaccines immunogenicity should be improved. The only method validated in Russia is a HAI (haemagglutination inhibition) assay with serum samples from vaccinated
Externí odkaz:
https://doaj.org/article/7c57458f56ac4bb19ac66f21f021b387
Autor:
I. V. Losev, S. A. Donina, G. D. Petukhova, D. A. Korenkov, E. P. Grigorieva, E. M. Doroshenko, L. G. Rudenko, A. N. Naykhin
Publikováno v:
Медицинская иммунология, Vol 17, Iss 4, Pp 347-358 (2015)
There exists a real hazard of transferring zoonotic influenza A viruses, either swine, or avian, into human population. In such case, severity of such pandemics depends on the pathogen-specific immunity in the population. Virtual absence of such immu
Externí odkaz:
https://doaj.org/article/6bab271b4d8f4bfca4092401973ac37d
Autor:
A. N. Naykhin, S. A. Donina, I. V. Losev, G. D. Petukhova, D. A. Korenkov, M. A. Stukova, M. К. Erofeeva, O. S. Konshina, T. A. Smolonogina, Е. М. Doroshenko, E. P. Grigorieva, L. G. Rudenko
Publikováno v:
Медицинская иммунология, Vol 17, Iss 1, Pp 59-70 (2015)
From the beginning of 21th century outbreaks of H5, H7 and H9 avian flu are registered from time to time. These viruses are considered as one of the possible causes of the next pandemia. The development of avian influenza vaccines is one of the WHO p
Externí odkaz:
https://doaj.org/article/70eec61f7aef48309cf9cfe90340deb0
Autor:
Larisa Rudenko, Irina Kiseleva, Anatoly N Naykhin, Marianna Erofeeva, Marina Stukova, Svetlana Donina, Galina Petukhova, Maria Pisareva, Vera Krivitskaya, Michael Grudinin, Zhanna Buzitskaya, Irina Isakova-Sivak, Svetlana Kuznetsova, Natalie Larionova, Julia Desheva, Irina Dubrovina, Alexandra Nikiforova, John C Victor, Kathy Neuzil, Jorge Flores, Vadim Tsvetnitsky, Oleg Kiselev
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e87962 (2014)
Live attenuated influenza vaccines (LAIVs) are being developed to protect humans against future epidemics and pandemics. This study describes the results of a double-blinded randomized placebo-controlled phase I clinical trial of cold-adapted and tem
Externí odkaz:
https://doaj.org/article/9328564510c147c09f55a719490ae6c3
Autor:
Nicholas Pearce, Tatiana Bousse, Anatoly Naykhin, Tatiana Smolonogina, Daniil Korenkov, Tatiana Tretiak, Donina Sa, Rekstin Ar, Svetlana Shcherbik, Larisa Rudenko, Irina Isakova-Sivak, Li-Mei Chen
Publikováno v:
Virology. 500:209-217
This study sought to improve an existing live attenuated influenza vaccine (LAIV) by including nucleoprotein (NP) from wild-type virus rather than master donor virus (MDV). H7N9 LAIV reassortants with 6:2 (NP from MDV) and 5:3 (NP from wild-type viru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22539cd42b87a2fe5de39ad21a360ffd
https://doi.org/10.1016/j.virol.2016.10.027
https://doi.org/10.1016/j.virol.2016.10.027
Autor:
Irina Isakova-Sivak, Daniil Korenkov, Irina Kiseleva, Larisa Rudenko, Victoria Matyushenko, Marina Stukova, Marie-Paule Kieny, Mariana Erofeeva, Anatoly Naykhin, Erin Sparrow
Publikováno v:
The Lancet Infectious Diseases. 16:303-310
Summary Background H7N9 avian influenza viruses characterised by high virulence and presence of mammalian adaptation markers have pandemic potential. Specific influenza vaccines remain the main defence. We assessed the safety and immunogenicity of an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b1d1342c270d62c870ccbc1f159a943
https://doi.org/10.1016/s1473-3099(15)00378-3
https://doi.org/10.1016/s1473-3099(15)00378-3